Stocks · Health care · Pharmaceutical Preparations

CorMedix Inc.

CRMD Clue Score73
United States Fiscal year ends December CIK 0001410098 Results filed 2 Nov 2026

What the insiders did No buying or selling

By person

13 insiders · 0 transactions
7.7×

Joseph Todisco holds 7.7 times base salary in stock. $5.33M of shares against $684.35K in salary for 2025.

Salary from the company's own proxy. The shares are what Joseph Todisco last reported holding, valued at $6.88, the price Common Stock was last bought or sold at on the open market here, on 21 Jan 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Joseph Todisco
Chief Executive Officer
—
—
—
774,749
$5.33M
+137.8%
Elizabeth Hurlburt
Chief Operating Officer
—
—
—
270,463
$1.86M
+631.5%
Kaufman Beth Zelnick
Chief Legal Officer
—
—
—
260,684
$1.79M
+810.8%
Myron Kaplan
Director
—
—
—
231,487
$1.59M
+53.3%
Michael David Seckler
Chief Commercial Officer
—
—
—
133,156
$916.11K
—
Steven W Lefkowitz
Director
—
—
—
125,951
$866.54K
+66.8%
Susan Blum
Chief Financial Officer
—
—
—
124,315
$855.29K
—
Janet Dillione
Director
—
—
—
117,835
$810.70K
+120.4%
Erin Mistry
EVP, Chief Commercial Officer
—
—
—
100,992
$694.82K
+94.2%
Matthew T David
Chief Financial Officer
—
—
—
95,270
$655.46K
+98.8%
Alan W Dunton
Director
—
—
—
70,703
$486.44K
+363.6%
Gregory Scott Duncan
Director
—
—
—
68,786
$473.25K
—
Robert A Stewart
Director
—
—
—
66,453
$457.20K
+504.1%

No percentages here. These insiders hold more than one class of share between them, and the share count on file covers one of them rather than all. Dividing the two would compare different things.